SYRE Financing Cash Flow

Spyre Therapeutics Inc · Financing Cash Flow

SYRE logo

SYRE Financing Cash Flow

Latest reported$753.03M
SYRE Cash from Financing ($5.58M → $753.03M)
High-resolution chart · PNG

SYRE financing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
309,025,000
410,906,000
361,077,000
42,678,000
1,393,000
154,512,000
65,723,000
57,068,000
12,213,000
49,370,000
41,674,000
5,575,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.